EcoDrugPlus

Alk Receptor Tyrosine Kinase

Ensembl ID : ENSSMAG00000012210
Gene Symbol: ALK
2 Cross references
193 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSSMAG00000028423
Gene Symbol: APEX1
1 Cross references
212 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSSMAG00000006568
Gene Symbol: APH1B
2 Cross references
190 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSSMAG00000009551
Gene Symbol: ABCC8
1 Cross references
225 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSSMAG00000009388
Gene Symbol: ATP1A2A
1 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1a

Ensembl ID : ENSSMAG00000000869
Gene Symbol: ATP1B1A
2 Cross references
225 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2a

Ensembl ID : ENSSMAG00000003385
Gene Symbol: ATP1B2A
2 Cross references
200 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSSMAG00000015277
Gene Symbol: ATP1B2B
3 Cross references
203 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSMAG00000011113
Gene Symbol: BRAF
1 Cross references
218 Possible Orthologues:

B2 Bradykinin Receptor

Ensembl ID : ENSSMAG00000017768
Gene Symbol: SI:DKEY-63B1.1
2 Cross references
155 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSSMAG00000002209
Gene Symbol: BCL2L1
3 Cross references
226 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSSMAG00000024868
Gene Symbol: BCL2L10
3 Cross references
128 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).